About

About Us

At Moterum, we believe good healthcare is designed to improve your life, not just your body. We are ready to spark a renaissance in good healthcare, and we want to start with the most challenging, under-served patient communities — because they, to, deserve the best standard of care.

As a stroke patient, your recovery needs are complex and your life and goals are unique. You deserve an integrative approach with a full team dedicated to your continuing care. Moterum’s Medicare and Medicaid-eligible health service is designed to give you a pathway of daily progress that will empower you to reach your own goals for independence. Our movement-based program provides you with human and technological support that’s proven to move patients forward — even if they’ve previously been told it “won’t get much better”. Your dedicated liaison, PT, OT and MD will be just as committed to your progress as you are. It’s how healthcare should be

When you become part of the Moterum community, you’ll get access to truly holistic, committed care.

Dedicated Liaison

PT, OT, and MD

In-home therapy

Remote monitoring

iStride technology

Personalized pathway

Tracking sensors

Moterum Daily Vistas

Daily Practices

In-app communication

In-app care management

In-app visible progress tracking

Welcome to Moterum. Ready to take a step forward with us?

Reach out today.

How We Serve

By providing enabling technology that will help stroke patients relearn how to walk safely and symmetrically, Moterum Technologies strives to change the lives of the 60 million plus stroke survivors, and millions of other neural trauma survivors around the world who struggle to walk on a daily basis.

The Moterum iStride Solution™ , covered by dozens of patent applications and issued patents, changes the gait of its user to re-pattern the user’s brain so they relearn how to walk, while monitoring, assessing, and engaging through a digital therapeutic platform. The device has successfully been used in clinical trials to help people walk faster, reduce fall risk, and improve balance. It is commercially available with a prescription

Partnerships

Our well-educated team maintains a diverse background dedicated to helping those in need by solving real-life problems. A list of our current products and descriptions is located here.

We design, develop, and test high impact products in the field of mobility and rehabilitation.

Our projects arise from recognizing the unsolved problems of mobility challenged people. We solve these problems with new technology that we develop to help you and your family live full, mobility independent lives. Our company is focused on sourcing, designing, engineering, manufacturing and selling the highest quality products to significantly impact people through addressing the problems of stroke rehabilitation and other chronic neural disorders.

Currently we have developed a next generation Moterum iStride Solution™, which has completed two clinical trials. We are also beginning clinical trials at Roger C. Peace Rehabilitation Hospital and the Greenville Health System in Greenville, SC with our lower limb stretching device for spasticity.

Leadership Team

LAUREN RASHFORD

LAUREN RASHFORD

President

Read More

Lauren is the President of Moterum Technologies.  Lauren has previously served as the Director of Clinical Operations and Customer Development. She holds a doctorate in physical therapy and brings substantial experience in the neuro-rehabilitation world, including clinical management and business development roles. With her strong background in both clinical and commercial rehabilitation, she offers expertise in clinical strategy and integration. Lauren has been responsible for clinical operations, building and leveraging clinic partnerships and delivering current protocols/education to other clinic staff. Additionally, Lauren will continue to cultivate, build, and maintain relationships that help foster the clinical integration process.

BRIE DARCY

BRIE DARCY

Clinical Research Manager

Read More

Brie Darcy, PT, DPT currently serves as the Clinical Research Manager for Moterum Technologies, Inc. Brie received a doctor of physical therapy degree with high honors from Emory University then dedicated 10+ years to clinical practice. In her patient care tenure, Brie served in various leadership positions at some of the nation’s most renowned medical centers and teaching hospitals including UCLA Medical Center and Atrium Health’s Carolinas Medical Center. She has extensive experience in neurorehabilitation, treating patient populations including those with strokes, spinal cord injuries, and neurodegenerative diseases. She is also skilled in post-surgical and critical care. As Clinical Research Manager for Moterum Technologies, Brie utilizes a strong clinical and research background to focus efforts on the design, implementation, and oversight of Moterum’s research studies.

GERALD MACCIOLI

GERALD MACCIOLI

Chief Medical Officer

Read More

Gerald Maccioli MD, MBA, FCCM, FASA currently serves as the Chief Medical Officer for MoterumTechnologies, Inc.

An exceptional and results-driven Clinician Strategist, Healthcare Administration Executive and Board-Certified Physician with extensive experience in all aspects of practice systems, physician services, anesthesiology, critical care medicine, transesophageal echocardiography, quality operations, finance, process improvement, patient safety, clinical research, investigator-led research, and care transformation.

Proven ability to develop and manage integrated clinical programs that ensure sound medical practices, achieve quality outcomes, and reach financial metrics. A visionary and resourceful turnaround specialist, catalyst for change, and a driver of results through the improvement of processes and operations.

KEY ACCOMPLISHMENTS

• Named one of 50 experts leading field of patient safety in 2018 by Becker’s.• Held national leadership roles in variety of organizations with keen eye to value-based care and operational excellence.• Broad experience working with national organizations as advocate on payment reimbursement reform models.• Invited national speaker at multiple conferences.

BOARD OF DIRECTORS

DAVID HUIZENGA

DAVID HUIZENGA

Founder

Read More

David E. Huizenga is the founder and CEO of Moterum Technologies Inc., a medical device company in stroke rehabilitation. He is an expert in translating groundbreaking science into realistic commercial opportunities. Over the last 5 years, he has focused his efforts on the unique needs of the neural rehabilitation patient. Previously, David was CEO and cofounder of Tao Life Sciences LLC, an early stage life sciences technology development and investment company, which successfully monetized over half of its portfolio. David has been on the founding team of numerous life science companies, and has involvement in successful acquisitions and exits. Mr. Huizenga obtained his Ph.D. from Harvard, in the laboratory of Jack Szostak, Nobel Laureate in Medicine, and his Law Degree from Emory University Law School, where he was a Woodruff Fellow. Mr. Huizenga serves on numerous corporate and non-profit boards.

MANOJ AGARWALA

MANOJ AGARWALA

Board Member

Read More

Manoj Agarwala is a serial entrepreneur. He successfully started and grew two technology companies – hCentive and GlobalLogic which grew to over 5,000 employees and expanded to over 6 countries. He was President and Chief Operating Officer for hCentive from 2009 to 2016. At hCentive Manoj oversaw the company’s Operations, Finance, Legal, R&D, Professional Services and Marketing.
COOPER COLLINS

COOPER COLLINS

Board Member

Read More

Mr. Cooper C. Collins, MBA, serves as the Managing Partner and CIO of MagnaSci Venture funds and as an Advisor to a number of pharmaceutical and biotechnology companies. Mr. Collins is the Founder and Advisor of Pernix Therapeutics Holdings, Inc. He served as the Chief Strategic Officer of Pernix Therapeutics Holdings, Inc. from May 2013 to April 15, 2014 and also served as its President from January 2007 to May 2013 and Chief Executive Officer from June 2008 to May 2013.

He served as the President and Chief Executive Officer of Pernix Therapeutics, LLC. From December 2005 to December 2007, he served as Vice President of Business and Product Development at Pernix and from December 2003 to December 2005, he served as Pernix’s Territory Manager. He was responsible for acquiring companies and products, attracting investors and increasing the overall efficiency. He served at the NFL franchise The New Orleans Saints in their media relations department for three years. He has been a Director of Oncternal Therapeutics, Inc. since February 22, 2017.

He has been an Independent Director of TherapeuticsMD, Inc. since February 28, 2012. He serves as a Director of Pernix Sleep, Inc. and Anthem Vault Inc. He served as a Director of Pernix Therapeutics Holdings, Inc. from January 1, 2007 to February 2014. Mr. Collins earned a BA and an MBA from Nicholls State University in Thibodaux, Louisiana.

KARAN SORENSEN

KARAN SORENSEN

Board Member

Read More

Karan Sorensen is an expert in digital health, information technologies, and the “internet of things”. Through her previous roles as a CIO and head of Digital Health for companies, such as Johnson & Johnson Pharmaceutical Research & Development LLC and Life Technologies, she pioneered global programs in the digital health arenas, such as Johnson and Johnson’s Total Oncology Digital Health Program.

Her excellence in the digital health world has garnered numerous awards including, Bio-IT World Best Practices, CIO magazine and CIO.COM awards including the CIO 100 award and CIO 100+ Competitive Advantage award. She has special expertise in executing innovation, information and technology solutions, building businesses, implementing operational excellence programs and developing leaders. Karan has been called a visionary and inspirational leader adept at shaping technical and business strategies, creating an energetic climate for growth and excellence, delivering large-scale goals, and motivating others to achieve their highest levels of growth and performance.

She has a reputation for excellence in creating high performance global teams and organizations and for administering multi-million dollar budgets. A technopreneur, Karan serves as a board member and advisor for technology start-ups, colleges, universities and industry standards organizations.

DAN ADAMS

DAN ADAMS

Board Member

Read More

Dan Adams is Co-Founder and Executive Chairman of NextWaveBio, a new company that is developing the next generation of safer, more affordable medicines. Previously he was CEO and then Executive Chairman of Protein Sciences Corporation, a leader in developing vaccines using its proprietary baculovirus expression vector (BEST) system. The US FDA licensed its lead vaccine, Flublok®, the first recombinant influenza vaccine, in January 2013, extended the age range in 2014 and approved the quadrivalent formulation in 2018. Flublok was also licensed in Mexico in 2016. The Company had a value of less than $2 million in 1996 and in 2017 it was acquired by Sanofi Pasteur for about $750 million. Previously Dan founded and managed several biotechnology companies that achieved a combined value of in excess of $70 billion. He co-founded Biogen in 1976 and was its first CEO; founded and was CEO of Advanced Genetic Sciences Inc., the first plant biotechnology company (Biogen and AGS were taken public in the 1980s), founded Plant Genetic Systems, the first European agricultural biotechnology company, and served as a managing director and chairman of the management committee (PGS was acquired by Agrivo for $750 million) and founded and was CEO of Allerx Inc. in 1999 – now a boutique company.
MARCUS OSBORNE

MARCUS OSBORNE

Board Member

Read More

KEITH PINTER

KEITH PINTER

Board Member

Read More

With more than 25 years of growth-oriented executive leadership in the healthcare provider and technology sectors, Mr. Pinter’s hallmark has been developing arena-changing ecosystems within industry segments experiencing structural discontinuities. He has strategically served as a catalyst for change, driven to improve clinical and business outcomes via technology enablement with success transitioning fee-for-service healthcare operations into value-based care. Keith’s proven abilities in market development, strategic development (M&A) and organizational development has enabled stakeholders in organizations ranging from entrepreneurial to Fortune 500 firms to realize substantial value.

Mr. Pinter has a proven record of achievement in leading organizations through rapid acquisitive and organic growth; possessing a unique combination of commercializing novel business models, operationalizing innovative technologies/platforms, rapidly scaling operations, and operating-at-scale. Keith is an exceptional team-builder, motivator and mentor with a history of building and leading high-performing teams towards consistent and crisp execution during turbulent times.

Keith’s focus on creating a new service delivery paradigm for the chronic disease ecosystem (which includes board leadership of Caduceus Medical, Chiron Psychological, Accolite Digital and cliexa) has led to the formation a platform acquisition investment company specializing in transforming the primary care provider segment into a sustainable risk-bearing enterprise.

ADVISORS

DAVID PERRYMAN

DAVID PERRYMAN

Chairman

Read More

David Perryman, J.D., is Chief Operating Officer of Drug Innovation Ventures at Emory University (DRIVE) in Atlanta.  He was formerly President, CEO and a founder of Zirus. David has played many roles in his 25 years in the biotechnology industry. In addition to Zirus, David has founded two other biotechnology companies: one was acquired and the second became a publicly traded company. David has served on the Board of Directors of these and other biotechnology companies.

Prior to joining Zirus, he was a shareholder and head of the Biotechnology Patent Practice group at Needle & Rosenberg, an IP boutique law firm. He practiced biotechnology patent law for 20 years delivering patent business strategy to biotech companies, venture capital funds, the CDC, NIH, FDA and numerous universities. He also served as a founder and special advisor to Georgia Venture Partners, a state associated biotech venture capital fund.

David served as a panelist at the Institute of Medicine’s Countermesure/Bioterrorism policy meeting (2010) as well as a featured presenter in Developments in Biodefense and Technology Platforms at the 8th Annual BioDefense Summit 2010. He received the 2014 Industry Growth Award from GaBio, considered the top award in Georgia for contribution to the state’s biotechnology industry.

DOUGLAS GOLDSTEIN

DOUGLAS GOLDSTEIN

Strategic Advisor

Read More

As a leader, Doug has developed innovative solutions using technology, big data, artificial intelligence and human ingenuity for healthcare leaders. Recently as the Innovation Officer for the Inova Center for Personalized Health he generated millions of dollars in translational research funding from global life sciences and medical devices companies. As the CEO of iConecto, Inc., Doug built mobile health and rehabilitation solutions for health systems. As the founder and CEO of Health Online, Inc. he developed the first syndicated health web portal service and acquired the first social network in health, as he grew revenues to a run rate of $10M. As an author and speaker, he has published 11 books and delivered 250 keynotes for 10,000 health executives.
ROBERT BADAL

ROBERT BADAL

Chief Revenue Officer

Read More

CHRIS GOLDSMITH

CHRIS GOLDSMITH

Read More

Over 20 years of success providing strategic business insights, executing large-scale projects, and driving companies to win in global marketplaces while maintaining corporate values and delivering benefits to key customers.

– Results-driven leader and strategic visionary with a consistent history of leveraging exceptional business acumen and an ability to delivery valuable solutions by merging business and technology perspectives. – Recognized as dedicated executive with track record of exceeding expectations and simultaneously executing on multiple projects and initiatives. – Competitive leader skilled in developing, empowering, and motivating teams to reach goals and peak performance levels.

Specialties: Strategic Analysis * Large-Scale Project Management & Execution * C-level & Industry Presentations * Product Roadmap Development * Global Product Launch * International Go-to-Market Strategies * Product Marketing * Global OEM & Reseller Agreement Negotiations * Team Building & Leadership

NATE KVAMME

Read More

Would you like to receive free updates about the Moterum iStride Solution™, and other breaking developments in stroke gait rehabilitation?

Share This